BrightPath Biotherapeutics Co., Ltd.
Notice on Monthly Exercise Status of the 21st Stock Acquisition Rights Allocated to a Third Party (with Exercise Price Adjustment Clause)
Exercises of stock acquisition rights occurred during the target month. Delivered shares: 1,624,500 shares; number of rights exercised: 16,245 rights (4.7% of total issued). As of the end of October 2026, unexercised rights totaled 345,000 rights (34,500,000 shares), and remaining unexercised shares were 328,755 rights (32,875,500 shares). Monthly exercise rate: 1.2%.
Key Figures
- Delivered shares: 1,624,500 shares
- Number of stock acquisition rights exercised: 16,245 rights
- Exercise rate: 1.2%
AI要約
Key Points of the News
Published the monthly exercise status of the 21st stock acquisition rights allocated to a third party. In October, a total of 1,624,500 shares were delivered, 16,245 rights were exercised, and the exercise rate relative to the total issued stock acquisition rights was 1.2%.
Market Impact and Outlook
Unexercised stock acquisition rights total 345,000 rights (34,500,000 shares), and remaining unexercised shares amount to 328,755 rights (32,875,500 shares), indicating limited dilution progression. It is necessary to monitor exercise trends in future monthly releases.
BrightPath Biotherapeutics Co., Ltd.
Company overview · Stock price · Financial data · All IR
